DE60323138D1 - Kombinationsarzneimittel aus r,r-formoterol und ciclesonide - Google Patents

Kombinationsarzneimittel aus r,r-formoterol und ciclesonide

Info

Publication number
DE60323138D1
DE60323138D1 DE60323138T DE60323138T DE60323138D1 DE 60323138 D1 DE60323138 D1 DE 60323138D1 DE 60323138 T DE60323138 T DE 60323138T DE 60323138 T DE60323138 T DE 60323138T DE 60323138 D1 DE60323138 D1 DE 60323138D1
Authority
DE
Germany
Prior art keywords
ciclesonide
formoterol
combination medicament
combination
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60323138T
Other languages
English (en)
Inventor
Klaus Dietzel
Degenhard Marx
Helgert Mueller
Christian Weimar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Nycomed GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed GmbH filed Critical Nycomed GmbH
Application granted granted Critical
Publication of DE60323138D1 publication Critical patent/DE60323138D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glass Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
DE60323138T 2002-12-12 2003-12-11 Kombinationsarzneimittel aus r,r-formoterol und ciclesonide Expired - Lifetime DE60323138D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027797 2002-12-12
DE10306213 2003-02-13
PCT/EP2003/014045 WO2004052374A1 (en) 2002-12-12 2003-12-11 Combination medicament

Publications (1)

Publication Number Publication Date
DE60323138D1 true DE60323138D1 (de) 2008-10-02

Family

ID=32509778

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60323138T Expired - Lifetime DE60323138D1 (de) 2002-12-12 2003-12-11 Kombinationsarzneimittel aus r,r-formoterol und ciclesonide

Country Status (15)

Country Link
US (2) US7879833B2 (de)
EP (1) EP1572217B1 (de)
JP (1) JP4755495B2 (de)
AT (1) ATE405275T1 (de)
AU (1) AU2003293833B2 (de)
CA (1) CA2508692C (de)
DE (1) DE60323138D1 (de)
DK (1) DK1572217T3 (de)
ES (1) ES2312844T3 (de)
HR (1) HRP20050611B1 (de)
IS (1) IS2597B (de)
PL (1) PL375819A1 (de)
PT (1) PT1572217E (de)
RS (1) RS51707B (de)
WO (1) WO2004052374A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8025896B2 (en) 2001-07-16 2011-09-27 Depuy Products, Inc. Porous extracellular matrix scaffold and method
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
CA2528479A1 (en) 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
CA2538419C (en) 2003-09-16 2012-07-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
EP1796679A1 (de) * 2004-09-10 2007-06-20 Altana Pharma AG Ciclesonid- und syk-hemmerverbindung und verfahren zu ihrer verwendung
WO2011093814A2 (en) * 2010-01-29 2011-08-04 Mahmut Bilgic A pharmaceutical combination comprising formoterol and ciclesonide
BR112013008974A2 (pt) * 2010-10-12 2023-12-19 Cipla Ltd Composição farmacêutica, processo para fabricar uma composição farmacêutica e uso de uma composição farmacêutica

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166396D1 (en) * 1980-02-27 1984-11-08 Tate & Lyle Plc Crystalline glucose and process for its production
US4816445A (en) * 1984-06-21 1989-03-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Crystalline alpha-maltose
JP2518646B2 (ja) * 1987-05-29 1996-07-24 株式会社 林原生物化学研究所 マルト−ス粉末の製造方法
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DE407028T1 (de) 1989-05-31 1994-03-17 Fisons Plc Medikament und Inhalationsvorrichtung dafür.
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
JP3042866B2 (ja) 1989-09-08 2000-05-22 グラクソ・グループ・リミテッド 呼吸疾患治療薬
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
US5178866A (en) * 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
EP0540670B1 (de) * 1990-07-26 1996-03-20 Monsanto Company Verfahren zur herstellung vernetzter polyamine
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
US5434304A (en) * 1990-09-26 1995-07-18 Aktiebolaget Astra Process for preparing formoterol and related compounds
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US6866839B2 (en) * 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
PT656207E (pt) * 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
ATE213946T1 (de) 1991-12-18 2002-03-15 Formoterol und budesonide enthaltende zusammensetzung
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
NZ265054A (en) 1993-04-02 1997-08-22 Byk Gulden Lomberg Chem Fab 16-hydroxy prednisolone cyclohexanecarboxaldehyde acetal derivatives
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of drug patramulations
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US6136839A (en) * 1995-06-12 2000-10-24 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
WO1997011705A1 (en) * 1995-09-26 1997-04-03 Takeda Chemical Industries, Ltd. Phosphorylamides, their preparation and use
DE19635498A1 (de) 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
SE9603725D0 (sv) 1996-10-11 1996-10-11 Astra Ab New teatment
US6380222B2 (en) * 1996-10-11 2002-04-30 Astrazeneca Ab Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
FR2754712B1 (fr) * 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
ES2178015T3 (es) 1996-11-11 2002-12-16 Sepracor Inc Procedimiento de preparacion de isomeros de formoterol opticamente puros.
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US6613795B2 (en) * 1996-11-11 2003-09-02 Christian Noe Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB2329939A (en) * 1997-06-26 1999-04-07 Glaxo Group Ltd Self-lubricating valve stem for aerosol containers
US6470894B2 (en) 1997-09-19 2002-10-29 Thione International, Inc. Glutathione, green tea, grape seed extract to neutralize tobacco free radicals
ATE215820T1 (de) 1997-10-08 2002-04-15 Sepracor Inc Dosierungsform zur verabreichung von aerosolen
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
DE69839735D1 (de) * 1997-12-15 2008-08-28 Astellas Pharma Inc Pyrimidin-5-carboxamid-derivate
SE9801368D0 (sv) 1998-04-20 1998-04-20 Astra Ab New use
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
ATE283033T1 (de) * 1998-07-24 2004-12-15 Jago Res Ag Medizinische aerosolformulierungen
EP1102579B1 (de) * 1998-08-04 2003-03-19 Jago Research Ag Medizinische aerosolformulierungen
PL193616B1 (pl) 1998-09-23 2007-02-28 Altana Pharma Ag Tetrahydropirydoetery
PT1283036E (pt) * 1998-11-13 2008-03-06 Jagotec Ag Inalador de pó seco de dose múltipla com um reservatório de pó
US6352152B1 (en) 1998-12-18 2002-03-05 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6124268A (en) * 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
JP2001048807A (ja) 1999-08-04 2001-02-20 Wakamoto Pharmaceut Co Ltd 難溶性薬物を水に溶解してなる製剤
DE19947234A1 (de) 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
GB0002336D0 (en) 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
GB0009607D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0012261D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0015043D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
FI20002177A0 (fi) 2000-10-02 2000-10-02 Orion Yhtymae Oyj Uusi yhdistelmä astman hoitoon
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
WO2002038155A1 (en) * 2000-11-07 2002-05-16 Merck & Co., Inc. Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist
IL156308A0 (en) * 2000-12-22 2004-01-04 Glaxo Group Ltd Metered dose inhaler for salmeterol xinafoate
ES2291452T3 (es) * 2001-02-06 2008-03-01 Innovata Biomed Limited Formulacion bimodal de polvo seco para inhalacion.
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
WO2003006310A1 (fr) 2001-07-13 2003-01-23 Tfe Techniques Et Fabrications Electroniques Dispositif destine a indiquer acoustiquement a un plongeur equipe d'un scaphandre la pression de gaz de respiration dans le reservoir et/ou la pression hydrostatique
CA2464250C (en) * 2001-10-24 2008-08-05 Frank-Christophe Lintz Kit for the preparation of a pharmaceutical composition
EP1453743B1 (de) * 2001-11-17 2008-07-23 Aventis Pharma Limited Pharmazeutisches produkt und verfahren mit adsorber
CA2467652A1 (en) * 2001-11-19 2003-05-30 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
ITMI20020808A1 (it) * 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
BRPI0312377A8 (pt) * 2002-07-02 2015-12-15 Altana Pharma Ag Suspensão aquosa estéril contendo ciclesonida
PL373433A1 (en) * 2002-08-30 2005-08-22 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
CA2525943A1 (en) 2003-05-22 2004-12-02 Altana Pharma Ag Salmeterol and ciclesonide combination
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
CA2528479A1 (en) 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
CA2538419C (en) * 2003-09-16 2012-07-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases

Also Published As

Publication number Publication date
EP1572217A1 (de) 2005-09-14
IS7910A (is) 2005-06-23
JP2006514686A (ja) 2006-05-11
CA2508692A1 (en) 2004-06-24
HRP20050611B1 (hr) 2013-12-20
HRP20050611A2 (en) 2006-09-30
DK1572217T3 (da) 2008-12-15
ES2312844T3 (es) 2009-03-01
PT1572217E (pt) 2008-11-28
PL375819A1 (en) 2005-12-12
US20060025392A1 (en) 2006-02-02
US7879833B2 (en) 2011-02-01
US8258124B2 (en) 2012-09-04
IS2597B (is) 2010-03-15
EP1572217B1 (de) 2008-08-20
RS20050429A (en) 2007-12-31
CA2508692C (en) 2012-04-03
ATE405275T1 (de) 2008-09-15
US20110086827A1 (en) 2011-04-14
JP4755495B2 (ja) 2011-08-24
AU2003293833B2 (en) 2009-10-01
RS51707B (sr) 2011-10-31
AU2003293833A1 (en) 2004-06-30
WO2004052374A1 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
IL173204A0 (en) Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
AU2003293757A1 (en) Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
SE0301653D0 (sv) Novel compounds
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
HK1076095A1 (en) Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
IS2597B (is) Lyf samsett úr R,R-formóteróli og siklesóníði
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
ES1053382Y (es) Protesis dilatadora del vestibulo nasal.
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
SI1532141T1 (sl) 2-pirolidin-2-il-(1,3,4)-oksadiazolni derivati in njihova uporaba kot antidepresivi
HK1095584A1 (en) Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same
DE60319388D1 (de) C6- UND C9-SUBSTITUIERTE CHROMENOÄ4,3-cÜISOXAZOLIN
RU2003110288A (ru) Вещество, обладающее антидепрессивной активностью
BRPI0410638A (pt) derivados de azitromicina
RU2002117643A (ru) Люплатекс, обладающий противолучевыми свойствами
RU2002107007A (ru) Туберкулостатическое средство
RU2002124805A (ru) Применение хлорхолинхлорида в качестве противоопухолевого средства
ITRM20030440A0 (it) Sistema d'indicazione temporale, in particolare dell'orario.
RU2003103889A (ru) Антигипоксический препарат
RU2003117895A (ru) Способ местного лечения неспецифических заболеваний эндобронхитов
RU2003120857A (ru) Адаптогенное средство

Legal Events

Date Code Title Description
8364 No opposition during term of opposition